Society for Women's Health Research

Focus on Fibroids Series: Tools to Navigate Optimal Care
2021-11-29 15:00 - 16:00 (America/New_York) | Virtual Event
Uterine fibroids (leiomyomas) are non-malignant growths of the uterus and one of the most common gynecological conditions nationwide. A growing and overlooked public health issue, fibroids affect approximately 26 million American women between the ages 15 to 50, however fibroids can affect patients across life stages from adolescence to post-menopause.
With a wide array of common symptoms, such as severe and irregular menstrual bleeding, pelvic and pain back, bladder or bowel dysfunction, and challenges with fertility, fibroids can result in significant health issues. Further, women with fibroids can experience delays in diagnosis due to stigma around menstrual disorders and normalization of symptoms by both patients and healthcare providers alike.
Diagnosing and treating uterine fibroids often requires a personalized approach that combines an assessment of a patient’s values and needs with medical treatments and wellness strategies to help each individual maintain a full and high quality of life. The Society for Women’s Health Research has created educational materials to increase awareness and understanding of uterine fibroids and help individuals with uterine fibroids navigate their care.
SWHR hosted this webinar as part of its Focus on Fibroids Series: Empowering Women to Live Well with Uterine Fibroids to share educational information about uterine fibroids, including diagnosis, treatment options, access to care, and disparities, as well as highlight the experiences of women living with fibroids.
The SWHR Focus on Fibroids series includes:

Congressional Briefing: Supporting Women with Fibroids Through Policy Action (July 13, 2021)
Tools to Navigate Optimal Care (November 29, 2021): this event
Empowering Women through Personal Journey-telling (December 6, 2021)

Check out the new Uterine Fibroids Toolkit: A Patient Empowerment Guide to learn more about risks and treatments.
Follow along on social media at #SWHRtalksFibroids.
